WallStreetZenWallStreetZen

NASDAQ: STLN
Starling Oncology Inc Stock Ownership - Who owns Starling Oncology?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Starling Oncology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Brad HivelyDirector2026-08-21298,853$6.51
$1.95MSell
Jorey Chernett10% Owner2026-08-1412,000$6.54
$78.48kBuy
Jorey Chernett10% Owner2026-07-2118,000$5.27
$94.86kBuy
Yale PodnosChief2026-07-145,478$6.35
$34.79kSell
Yale PodnosChief2026-07-1417,974$6.43
$115.55kSell
Yale PodnosChief2026-07-145,478$2.00
$10.96kBuy
Yale PodnosChief2026-07-1417,974$1.87
$33.61kBuy
Jorey Chernett10% Owner2026-07-1015,000$5.85
$87.75kBuy
Jorey Chernett10% Owner2026-06-2318,000$5.02
$90.36kBuy
Yale PodnosChief Medical Officer2026-06-0823,451$5.38
$126.10kSell

1 of 4

STLN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when STLN insiders and whales buy or sell their stock.

STLN Shareholders

What type of owners hold Starling Oncology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ravi Yang Sarin12.17%12,404,740$82.62MInsider
Jorey Chernett10.46%10,660,858$71.00MInsider
Richard A. Barasch6.99%7,126,571$47.46MInsider
M33 Growth I LP5.34%5,444,207$36.26MInsider
James E. Flynn3.23%3,296,107$21.95MInsider
Daniel Virnich2.29%2,337,166$15.57MInsider
Mark L. Pacala0.50%511,852$3.41MInsider
Mihir 1. Shah0.47%474,931$3.16MInsider
Robert Ross Carter0.41%414,801$2.76MInsider
Brad Hively0.40%411,976$2.74MInsider

1 of 3

STLN vs Medical Care Facility Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
STLN0.04%45.35%Net BuyingNet Selling
GMRS0.09%36.48%Net SellingNet Selling
MCTA0.00%11.64%
SRTA0.06%30.68%Net SellingNet Selling
CYH0.08%45.92%Net SellingNet Selling
View Top Medical Care Facility Stocks

Starling Oncology Stock Ownership FAQ

Who owns Starling Oncology?

Starling Oncology (NASDAQ: STLN) is owned by 0.04% institutional shareholders, 45.35% Starling Oncology insiders, and 54.61% retail investors. Ravi Yang Sarin is the largest individual Starling Oncology shareholder, owning 12.40M shares representing 12.17% of the company. Ravi Yang Sarin's Starling Oncology shares are currently valued at $82.62M.

If you're new to stock investing, here's how to buy Starling Oncology stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.